Mitsui & Company makes strategic investment in Avon Organics’ parent company

17 Jan 2013 Evaluate

Japan based Mitsui & Company has made a strategic investment in Avon Organics’ parent company - Arch Pharmalabs (Arch) through a secondary market transaction, whereby the Japanese company has purchased 27.29% equity capital of Arch from private equity investors.

The transaction has been completed on January 16, 2013. Subsequent to which Mitsui & Company’s shareholding in Arch has increased from 4.67% to 31.96%.

Arch presently hold 63.60% equity capital of Avon Organics thereby making it a subsidiary company. However, there is no change envisaged/contemplated in the control and management of Arch Pharmalabs and/or at Avon Organics, pursuant to strategic investment by Mistui & Company in Arch.

Kobo Biotech Share Price

4.66 -0.24 (-4.90%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.